Arcadia Investment Management’s Dyne Therapeutics DYN Stock Holding History

Arcadia Investment Management’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$897K	Buy	49,475 +1,600	+3%	+$27.6K	0.15%	70
2025 Q4	$936K	Sell	47,875 -1,350	-3%	-$25.6K	0.15%	71
2025 Q3	$623K	Sell	49,225 -5,990	-11%	-$68.3K	0.1%	83
2025 Q2	$526K	Buy	55,215 +10,350	+23%	+$114K	0.08%	88
2025 Q1	$469K	Sell	44,865 -75	-0.2%	-$1.07K	0.08%	91
2024 Q4	$1.06M	Buy	44,940 +6,326	+16%	+$187K	0.17%	71
2024 Q3	$1.39M	Buy	38,614 +3,439	+10%	+$137K	0.23%	63
2024 Q2	$1.24M	Buy	35,175 +3,850	+12%	+$112K	0.21%	65
2024 Q1	$889K	Buy	+31,325	New	+$708K	0.16%	67

Other funds holding DYN

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Arcadia Investment Management's DYN Position: Q1 2026 in Review

Arcadia Investment Management increased its Dyne Therapeutics (DYN) stake by 3.3% in Q1 2026, buying an estimated $27.6K and bringing the position to 49,475 shares worth $897K. The position accounts for 0.15% of the portfolio, ranked #70.

Arcadia Investment Management first reported a position in DYN in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.39M in Q3 2024. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

Arcadia Investment Management held 49,475 shares of Dyne Therapeutics worth $897K as of Q1 2026.
Arcadia Investment Management bought 1,600 Dyne Therapeutics shares in Q1 2026, an estimated $27.6K.
Dyne Therapeutics made up 0.15% of Arcadia Investment Management's portfolio in Q1 2026, its #70 holding.
Arcadia Investment Management first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 9 quarters since.
Arcadia Investment Management's Dyne Therapeutics position peaked at $1.39M in Q3 2024.
227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Arcadia Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.